HemoGenyx Pharmaceuticals Plc (HOPHF)

2.33 0.00 (0.00%) USD  |  OTCM  |  Oct 09, 16:00
More

HemoGenyx Pharmaceuticals Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for HOPHF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to . Start Trial.
Date Value

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Silence Therapeutics Plc Upgrade
Biodexa Pharmaceuticals Plc Upgrade
NuCana Plc Upgrade
Mereo BioPharma Group Plc Upgrade
Compass Pathways Plc Upgrade